The company will be participating in an Investor Conference titled "CLSA Speaker Session India GenAI" as part of their Analyst/Investor meetings.
The event is scheduled for June 11, 2026, at 6:00 PM IST.
The format will be virtual, and the type of interactions will be group meetings.
The stated purpose is interaction with Investors/Analysts, specifically focusing on the GenAI theme in India.
The company explicitly stated that "Discussions will be based on publicly available information" and that "No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions."
Management participants were not specifically named in the disclosure. The letter was signed by Sridhar Muthukrishnan, Company Secretary and Compliance Officer.
The disclosure does not mention if a presentation, earnings deck, transcript, or recording will be made available.
Additional Notes Section
This intimation is a regulatory filing made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The letter includes a note that changes to the schedule may occur "due to exigencies on the part of Investors / Analysts / Company."
The information is also being hosted on the Company's website at https://www.amagi.com/investors/notifications.
No financial data, guidance references, or presentation summaries were included in this specific announcement.
